FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.87B
AUM Growth
+$366M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
56
New
Increased
Reduced
Closed

Top Buys

1
+$22.3M
2
+$19.9M
3
+$16.2M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$16.1M
5
DYN icon
Dyne Therapeutics
DYN
+$15.8M

Top Sells

1
+$42.4M
2
+$14.3M
3
+$8.71M
4
REPL icon
Replimune Group
REPL
+$6.62M
5
PRTA icon
Prothena Corp
PRTA
+$6.17M

Sector Composition

1 Healthcare 99.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$19.7M 1.05%
2,142,855
27
$19.3M 1.03%
899,700
28
$18.8M 1.01%
4,000,000
29
$18.7M 1%
464,937
30
$16.7M 0.89%
393,000
31
$16.5M 0.88%
1,021,800
+651,800
32
$16.1M 0.86%
+69,406
33
$15.8M 0.84%
+1,184,840
34
$15.3M 0.82%
881,173
35
$14.2M 0.76%
1,026,420
-1,593
36
$14.1M 0.76%
397,483
-1,192,448
37
$12.9M 0.69%
+317,190
38
$11.7M 0.63%
285,331
39
$11.7M 0.63%
1,995,267
+493,884
40
$11.7M 0.62%
523,166
+231,164
41
$11.2M 0.6%
400,000
42
$9.89M 0.53%
7,381,090
+500,000
43
$8.58M 0.46%
2,118,051
-130,143
44
$6.21M 0.33%
203,684
45
$4.7M 0.25%
+80,000
46
$2.36M 0.13%
85,495
47
$2.1M 0.11%
1,030,878
-400,000
48
$1.57M 0.08%
500,333
49
$278K 0.01%
264,377
50
– –
-1,647,030
1
2
3